RARE offers to acquire DMTX for $5.50/sh cash—a 62% premium to RGNX’s offer in August (#msg-134124483): https://finance.yahoo.com/news/ultragenyx-proposes-acquire-dimension-therapeutics-123500484.html DMTX trading is currently halted.